Results 201 to 210 of about 4,624,933 (258)

Centratherin Exhibits Antitumor Activity Against Glioblastoma Cells. [PDF]

Neurochem Res
Mafra de Faria B, Leme da Silva Pinheiro F, Medeiros I, Lobo JFR, Teixeira AM, Machado Rocha L, Borges RM, Rossi MID, de Andrade LC, Pontes B, Dubois LG, Romão LF.   +11 more
europepmc   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

Biological Effects of Selenium-Containing Ionic Liquids: Cytotoxicity, Mercury Interaction, and Antiproliferative Activity in Glioblastoma Cells. [PDF]

J Appl Toxicol
Rieder GS, de Souza Prestes A, D'Avila da Silva F, de Vargas Barbosa N, Bastidas Ángel AY, Soares MF, Fernandes CM, Petersen MAO, Silva MM, Scholl JN, Figueiró F, Nogara PA, Orian L, Alberto EE, Ascnher M, de Souza DOG, de Souza DG, da Rocha JBT.   +17 more
europepmc   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

BMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo, Shun Yao, Lihui Meng, Chunyuan Chen, Yuechu Lucinda Lu, Rong Lu, Kashif Rafiq Zahid, Umar Raza, Qingzhi Wu, Wenli Chen   +9 more
wiley   +1 more source

Hypoxia Increases Connexin46 and Connexin43 Levels in KNS-42 Glioblastoma Cells. [PDF]

Int J Mol Sci
Minogue PJ, Beyer EC, Berthoud VM.
europepmc   +1 more source

Glycosylated dendrimer nanoamplifiers hijack DNA damage‐immune crosstalk for enhanced dual‐track therapy of orthotopic glioblastoma

BMEMat, EarlyView.
A glycosylated dendrimer nanoamplifier hijacks DNA damage‐immune crosstalk for enhanced radio‐immunotherapy of glioblastoma. The responsive release of demethylcantharidin simultaneously blocks repair‐mediated resistance by inhibiting DNA repair and overcomes adaptive immune resistance.
Cong Song, Binghan Liu, Junjie Liu, Ce Li, Wenqing Man, Xurui Sun, Chang Yuan, Yanjun Wang, Hong Pan, Shuanglian Wang, Zhiming Zheng   +10 more
wiley   +1 more source

The Time-Dependent Effects of Temozolomide on Autophagy Gene Expression in Glioblastoma Cells. [PDF]

Biomedicines
Kiraz İ, Aydın VK, Kurt Ö, Coşkun ME, Lengerova G, Bozhkova M, Petrov S, Köseler A.   +7 more
europepmc   +1 more source

Nanomedicine‐driven innovations in postoperative cancer immunotherapy: Remodeling tumor microenvironment and precision delivery strategies

BMEMat, EarlyView.
Nanomedicine‐Driven Strategies for Suppressing Postoperative Tumor Recurrence. This schematic illustrates three pivotal nanomedical strategies that synergistically counteract recurrence by targeting residual disease and the immunosuppressive tumor microenvironment within the surgical cavity.
Lisong Pang, Zhuomin Wang, Zhenhua Jin, Ahmed H. Ghonaim, Hengcheng Zhang, Xinyu You, Jinzhuo Ning, Jiaqing Cao, Yang Liu   +8 more
wiley   +1 more source

Glycosylated Delphinidins, Natural Antioxidants, Functionally Modulate the COX-2/PGE₂ Axis and Downregulate MDR1 in Glioblastoma Cells. [PDF]

Antioxidants (Basel)
Cuevas C, Nahuelpan Y, Haro D, Silva P, Villagran V, Gleisner MA, Salazar-Onfray F, Muñoz JP, Pávez C, Garcia-Romero N, Ayuso-Sacido A, Martin RS, Carrillo-Beltrán D, Quezada-Monrás C.   +13 more
europepmc   +1 more source